8/20/2013 6:25:30 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
In patients with early Alzheimer's disease, disruptions in brain networks emerge about the same time as chemical markers of the disease appear in the spinal fluid, researchers at Washington University School of Medicine in St. Louis have shown. While two chemical markers in the spinal fluid are regarded as reliable indicators of early disease, the new study, published in JAMA Neurology, is among the first to show that scans of brain networks may be an equally effective and less invasive way to detect early disease.
Hey, check out all the engineering jobs. Post your resume today!
comments powered by